| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Apr―29 |
The viral oncogenesis of COVID-19 and its impact on cancer progression, long-term risks, treatment complexities, and research strategies |
Moawiah M Naffaa, Ola A Al-Ewaidat |
| 2 |
[GO] |
2025―Apr―21 |
Long-term neurological and otolaryngological sequelae of COVID-19: a retrospective study |
Wael Abu Ruqa, Christian Barbato, Antonio Minni |
| 3 |
[GO] |
2025―Feb―19 |
Prevalence of COVID-19 associated xerostomia, taste and smell disturbances over 3 years in an Egyptian sample: a cross-sectional study |
Dalia Ghalwash, Ahmed Hamdy, Asmaa Abou-Bakr |
| 4 |
[GO] |
2024―Apr―09 |
The coevolution of Covid-19 and host immunity |
Azizul Haque, Anudeep B. Pant |
| 5 |
[GO] |
2023―Nov―01 |
Figuring the characteristics of the Delta variant SARS-CoV-2 gene mutations in an Indonesian hospital: a descriptive study |
Phey Liana, Muhammad Agung Maulana, Eny Rahmawati, Rouly Pola Pasaribu, Kemas Yakub Rahadiyanto, Nelda Aprilia Salim, Tungki Pratama Umar |
| 6 |
[GO] |
2023―Aug―31 |
Cannabis-based medicinal products (CBMPs) for the treatment of Long COVID symptoms: current and potential applications |
Hannah Thurgur, Anne Katrin Schlag, Elizabeth Iveson, Adele Hosseini, Michael Lynskey, David J. Nutt |
| 7 |
[GO] |
2023―Jun―28 |
The impact of COVID-19 pandemic on diagnosis and management of gastrointestinal cancers |
Byung Soo Yoo, Ankit Patel, Kevin V. Houston, Alejandra Vargas, Ana Rosa Vilela Sangay, Steve M. D’Souza, David A. Johnson |
| 8 |
[GO] |
2023―Jun―28 |
Association between coronavirus 2019 disease and pseudoneurological complaints: analysis of case-control data |
Mohammad Ali, Atia Sharmin Bonna, Tajnuva Mehjabin |
| 9 |
[GO] |
2023―Apr―26 |
Gastrointestinal microbiome and coronavirus disease: evidence of a bidirectional association |
Kevin V. Houston, Ankit Patel, Michael Saadeh, Alejandra Vargas, Ana Rosa Vilela Sangay |
| 10 |
[GO] |
2023―Apr―26 |
Mechanistic approaching study in COVID-19 patients treated with high doses of vitamin D |
Mauro G. Silva, Felipe Inserra, Javier Mariani, Laura Antonietti, Myriam Nuñez, Carlos Tajer, et al. (+10) León Ferder, Pablo I. F. Inserra, Fernando Ross, Milagro Sánchez Cunto, Magalí Bertelli, Gabriela de Larrañaga, Eliana M. Cela, Daniel H. González Maglio, Mariela M. Gironacci, Walter Manucha |
| 11 |
[GO] |
2023―Apr―26 |
Immunomodulation strategies against COVID-19 evidence: key nutrients and dietary approaches |
Lindsey B. Cundra, Manasa Vallabhaneni, Michael Saadeh, Kevin V. Houston, Byung Soo Yoo, Steve D’Souza, David A. Johnsonv |
| 12 |
[GO] |
2023―Mrz―01 |
m6 RNA methylation: an emerging common target in the immune response to cancer and severe acute respiratory syndrome-coronavirus-2 infection |
Hiromichi Sato, Tomoaki Hara, Chihiro Otsuka, Yasuko Arao, Yoshiko Tsuji, Yumiko Hamano, et al. (+5) Mirei Ogita, Eric di Luccio, Takaaki Hirotsu, Andrea Vecchione, Hideshi Ishii |
| 13 |
[GO] |
2023―Feb―27 |
Molecular docking analysis of peptide-based antiviral agents against SARS-CoV-2 main protease: an approach towards drug repurposing |
Abhishek Chaurasiya, Abhimannu Shome, Pooja A. Chawla |
| 14 |
[GO] |
2022―Dez―30 |
Incursions by severe acute respiratory syndrome coronavirus-2 on the host anti-viral immunity during mild, moderate, and severe coronavirus disease 2019 disease |
Saksena Nitin, Bonam Srinivasa R., Miranda-Saksena Monica, Cardoso Thyago H. |
| 15 |
[GO] |
2022―Dez―29 |
Right atrial thrombus, junctional tachycardia, and critical lower limb ischemia: three rare complications of severe acute respiratory syndrome coronavirus 2 infection |
Said Makani, Aziza Laarje, Meryem Mabrouk, Younes Zaid, Malak Chahid, Zaynab Hifdi, et al. (+4) Meriem Azhari, Chafik Elkettani, Hicham Belmir, Youssef Tijani |
| 16 |
[GO] |
2022―Jun―09 |
Early taurine administration as a means for halting the cytokine storm progression in COVID-19 patients |
Alberto Rubio-Casillas, Ramesh C. Gupta, Elrashdy M. Redwa, Vladimir N. Uversky, Raied Badierah |
| 17 |
[GO] |
2022―Jan―25 |
Fertility and COVID-19 vaccination |
Iosif M. Gershteyn |
| 18 |
[GO] |
2022―Jan―18 |
Preclinical toxicity test results of a new antiviral-immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data) |
Gürer G. Budak, Seçil Özkan, Mehmet Budak, Tamay Şeker, Bahar Meryemoglu, Şükran Selin Miran, et al. (+2) Canan Çakır Çoban, Orkun Tarkun |
| 19 |
[GO] |
2021―Dez―31 |
Preclinical toxicity test results of a new antiviral-immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data) |
Gürer G. Budak, Seçil Özkan, Mehmet Budak, Tamay Şeker, Bahar Meryemoglu, Şükran Selin Miran, et al. (+2) Canan Çakır Çoban, Orkun Tarkun |
| 20 |
[GO] |
2021―Okt―09 |
A review of aortic thrombosis in COVID-19 infection |
Korin Karabulut, Ahmet Kapici, Ana Andronikashvili, James Morgan |
| 21 |
[GO] |
2021―Aug―30 |
High prevalence of false positive SARS-CoV2 serology in a cohort of patients with liver autoimmune diseases |
Maria Giulia Cornacchia, Moris Sangineto, Rosanna Villani, Francesco Cavallone, Giuseppe Di Gioia, Paola Cicciomessere, Gaetano Serviddio |
| 22 |
[GO] |
2021―Apr―27 |
Angiotensin-(3-4) modulates the overweight- and undernutrition-induced ACE2 downregulation in renal proximal tubule cells: implications for COVID-19? |
Rafael Luzes, Humberto Muzi-Filho, Amaury Pereira-Acácio, Thuany Crisóstomo, Adalberto Vieyra |
| 23 |
[GO] |
2020―Okt―31 |
High-performance computing will assist experiments in recovery from COVID-19 |
|
| 24 |
[GO] |
2020―Jul―17 |
Visual communication and learning from COVID-19 to advance preparedness for pandemics |
José de la Fuente, José Bedia, Christian Gortázar |
